Search clinical trials for: Metformin/Acarbose

Total 2250 results

Bayer

Completed

Bioequivalence Study for Acarbose / Metformin FDC

Diabetes Mellitus, Type II

Korea, Republic of
Lotus Pharmaceutical

Unknown

A Phase III Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg Plus Acarbose 50 mg Tablets) Versus Acarbose Alone in Subjects With Type 2 Diabetes Mellitus

The Objectives of the Study is to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg | Plus Acarbose 50 mg Tablets) Thrice Daily Versus Acarbose 50 mg Thrice Daily Over 16 Weeks in | Subjects With Type 2 Diabetes Mellitus.

Taiwan
Royan Institute

Completed

Metformin Versus Acarbose Treatment in Infertile Overweight Women With Polycystic Ovary Syndrome (PCOS)

PCO

Iran, Islamic Republic of
Bayer

Active, not recruiting

A Study to Learn More About How Acarbose and Metformin Work When Taken Together and How Safe They Are in Indian Patients Who Were Recently Diagnosed With Type 2 Diabetes (T2D) (START-AM)

Type 2 Diabetes Mellitus

India
Bayer

Completed

GLucobay M OBservation Study for Efficacy and Safety in Treatment of Type-2 Diabetes Patients (GLOBE)

Type 2 Diabetes

India
Bayer

Withdrawn

GLucobay M - Evaluation Of Safety and Effectiveness in Type 2 Diabetes Not Well Controlled on Monotherapy in Real Life Practice (GLORY)

Diabetes Mellitus, Type 2
The Catholic University of Korea
Bayer

Completed

Study to Evaluate the Efficacy of Acarbose,Metformin,Sitagliptin Combination Treatment in DM Patients

Type 2 Diabetes Mellitus

Korea, Republic of
Bayer

Completed

Bioequivalence Study for Acarbose/Metformin FDC

Diabetes Mellitus, Type 2

China
Sanofi

Completed

Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)

Diabetes Mellitus, Type 2

China
Population Health Research Institute
Hamilton Health Sciences Corporation

Completed

Remission Evaluation of Metabolic Interventions in Type 2 Diabetes (REMIT Pilot Trial)

Type 2 Diabetes Mellitus

Canada
Japan Early Diabetes Intervention Study Group

Unknown

Japan Early Diabetes Intervention Study (JEDIS)

Diabetes Mellitus

Japan
Nanjing First Hospital, Nanjing Medical University

Recruiting

Effect of Acarbose and Mixture of Pioglitazone and Metformin in Patients With Type 2 Diabetes

Type 2 Diabetes | Blood Glucose Fluctuation

China
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Unknown

Effects of Liraglutid, Dapagliflozin and Acarbose on the Cognitive Function, Olfactory Function, and Odor-induced Brain Activation in Overweight/Obese T2DM Patients Controlled Inadequately With Metformin Monotherapy.

Obesity | Type 2 Diabetes Mellitus | Cognitive Impairment

China
Institute for Clinical and Experimental Medicine

Completed

Cardioprotective and Metabolic Effects of Metformin in Patients With Heart Failure and Diabetes (CARMET)

Insulin Resistance | Chronic Heart Failure

Czechia
Valme University Hospital

Completed

Treatment Insulin Resistence in HCV G-1 Patient (TRIC-1)

Chronic Hepatitis C

Spain
EMS

Completed

Efficacy and Safety of Oral Acarbose Treatment in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Brazil
Services Hospital, Lahore

Completed

Comparison of Hypoglycaemic Regimens During Ramadan Fasting in Type 2 Diabetes

Diabetes, Type 2

Pakistan
Bayer

Completed

Loose-dose Combination of Acarbose and Metformin for T2DM in Metformin-failure Patients

Diabetes Mellitus, Type 2

China
Third Affiliated Hospital, Sun Yat-Sen University

Recruiting

Comparison of Diabetes Retinopathy Among Type 2 Diabetic Patients Treated With Different Regimens (CORRECT)

Diabetic Retinopathy

China
Bayer

Completed

A 3-fold Crossover Bioequivalence Study Between Glucobay Orally Disintegrating Tablet (ODT) and Glucobay Standard Tablet

Diabetes Mellitus, Type 2

Germany
Bayer

Completed

A 3-fold Crossover Bioequivalence Study Between Glucobay ODT (Orally Disintegrating Tablet) 100 mg and Glucobay Standard Tablet 100 mg

Diabetes Mellitus, Type 2

Germany
Shanghai 6th People's Hospital

Unknown

the Efficacy of Acarbose and Metformin on Blood Glucose Fluctuation When Combined With Premix Insulin (CGMS)

Type 2 Diabetes

China
RenJi Hospital

Unknown

Research of Intensive Metabolic Intervention Before Pregnancy in PCOS (PCOS)

PCOS | Impaired Glucose Tolerance

China
J JESUS VENEGAS, MD
Instituto Mexicano del Seguro Social; National Council of Science and Technology...

Completed

Effect of Metformin and Rosiglitazone Over no Diabetic With Metabolic Syndrome Patients.

Insulin Resistance
Hormozgan University of Medical Sciences

Completed

Effect of Dosage of Metformin on Menstruation and Lipid Profile in Women With Polycystic Ovary Syndrome

Polycystic Ovary Syndrome

Iran, Islamic Republic of
Bayer

Withdrawn

Study to Assess the Dietary Carbohydrate Content of Indian Diabetics With Special Therapeutic View on Effectiveness of Acarbose and Metformin Monotherapy (STARCH AM)

Diabetes Mellitus
Guiyang Medical University

Not yet recruiting

Clinical Study of Radiotherapy Combined With Nedaplatin Contrast and Cisplatin for the Treatment of Locally Advanced Head and Neck Squamous Carcinoma

Head and Neck Squamous Carcinoma

China
Radboud University Medical Center

Completed

Vildagliptin and Endothelium-dependent Vasodilatation

Type 2 Diabetes | Endothelial Dysfunction

Netherlands
The Cleveland Clinic

Completed

Bexarotene Amyloid Treatment for Alzheimer's Disease (BEAT-AD)

Alzheimer's Disease

United States
Takeda

Completed

Efficacy and Safety of Voglibose Compared With Acarbose in Participants With Type 2 Diabetes

Type 2 Diabetes Mellitus

China
National Taiwan University Hospital
Merck Sharp & Dohme LLC; Schering-Plough

Unknown

The Effects of Oral Hypoglycemic Agents on Chronic Hepatitis C Patients Receiving Peg-Intron Plus Ribavirin

Chronic Hepatitis C

Taiwan
The University of Texas Health Science Center at...

Completed

Acarbose Anti-aging Effects in Geriatric Subjects (Substudy B & C)

Aging

United States
GWT-TUD GmbH
Technische Universität Dresden; University of Regensburg; Diakonissen Krankenhaus...

Completed

AI(I)DA Acarbose and the Subclinical Inflammation

Type 2 Diabetes Mellitus | Subclinical Inflammation

Germany
Assistance Publique Hopitaux De Marseille

Completed

Effect of GLP-1 Receptor (GLP-1R) Agonists on Cardiac Function and on Epicardial Adipose Tissue (EAT) Volume and on Myocardial TG Content in Obese Diabetics

Obesity | Diabetes

France
GWT-TUD GmbH

Completed

Metabolic Syndrome Risk Factor in IGT: STOP-NIDDM Trial

Metabolic Syndrome

Germany
Assistance Publique - Hôpitaux de Paris

Recruiting

Impact of Metformin on Peripheral Arterial Calcification in Type 1 Diabetes (IMPACT-1D)

Type 1 Diabetes | Peripheral Arterial Calcification

France
Technische Universität Dresden

Completed

Effects of Acarbose on Endothelial Function After a Mixed Meal in Newly Diagnosed Type 2 Diabetes

Type 2 Diabetes
Aichi Gakuin University

Unknown

Impact of Acarbose on Abnormal Glucose Regulation in Patients With Coronary Artery Disease (AAA Trial)

Coronary Artery Disease | Diabetes Mellitus | Impaired Glucose Tolerance

Japan
University of Texas Southwestern Medical Center

Completed

Preservation of Beta-cell Function in Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States
AgelessRx

Completed

The Efficacy and Tolerability of Acarbose in Healthy Individuals

Tolerance | Side Effect | Glucose Response

United States
Bayer

Completed

GlucoVIP - Diabetes Treatment by Glucobay® With a Special Therapeutic View to Chosen Patient Groups

Diabetes Mellitus

Russian Federation, India, Korea, Republic of, Indonesia, Malaysia, Philippines, Singapore, Thailand, China, Hong Kong, Pakistan, Vietnam, Algeria, Moldova, Republic of, Bosnia and Herzegovina, Cambodia
Karolinska Institutet
Bayer; The Swedish Research Council

Completed

Exercise and Acarbose in Type 2 Diabetes

Diabetes Mellitus Type 2

Sweden
Bayer

Completed

GlucoFriend-evaluation the Effectiveness of Glucobay When Combined With a Basal Insulin

Diabetes Mellitus

Korea, Republic of
Bayer

Completed

Influence of Different Approaches to Dietary Advising on the Effects of Acarbose Treatment in Obese Diabetic Patients Under Real-life Setting (CATERING)

Diabetes Mellitus

Poland
University of Alabama at Birmingham

Not yet recruiting

Acarbose in Combination With Standard Therapy in Metastatic Renal Cell Carcinoma (RCC)

Kidney Cancer

United States
Bayer

Completed

Special Drug Use Investigation of Glucobay OD

Diabetes Mellitus

Japan
Bayer

Completed

Prevent/Delay Development of Type 2 Diabetes in Subjects With Impaired Glucose Homeostasis Treated With Acarbose in Primary Care

Diabetes Mellitus

Spain
Bayer

Completed

Prevention of Postprandial Hyperglycemia by Acarbose May be a Promising Therapeutic Strategy for Reducing the Increased Risk for Cardiovascular Disease (ABDOMEN)

Diabetes Mellitus

Poland
Bayer

Completed

Diabetes Treatment With Glucobay in Combination With Metformin

Type 2 Diabetes Mellitus

India
Karolinska Institutet

Completed

Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes Subjects (Rebuild)

Diabetes | Atherosclerosis | Restenosis

Sweden

3

Subscribe